Koyfin Home > Directory > Health Care > Amphastar Pharma > EBIT

Amphastar Pharma EBIT Chart (AMPH)

Amphastar Pharma annual/quarterly EBIT from 2014 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Amphastar Pharma EBIT for the quarter ending December 12, 2018 was $2m a 703.24% increase of 11m year over year
  • Amphastar Pharma EBIT for the last 12 months ending December 12, 2018 was $-9m a -34.74% increase of 3m year over year
  • Amphastar Pharma Annual EBIT for 2018 was $-9m a 58.97% decrease of -5m from 2017
  • Amphastar Pharma Annual EBIT for 2017 was $-4m a 554.83% decrease of -20m from 2016
  • Amphastar Pharma Annual EBIT for 2016 was $16m a 122.36% increase of 20m from 2015
Other Income Statement Metrics:
  • Amphastar Pharma EBITDA for the quarter ending December 12, 2018 was $6m a 196.48% increase of 11m year over year
  • Amphastar Pharma Net Income for the quarter ending December 12, 2018 was $2m a 488.11% increase of 9m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH EBIT Data

12/2018$2m
09/2018$3m
06/2018$-3m
03/2018$-9m
12/2017$-2m
09/2017$-3m
06/2017$2m
03/2017$-1m
12/2016$-5m
09/2016$6m

Annual AMPH EBIT Data

2018$-9m
2017$-4m
2016$16m
2015$-4m
2014$-18m
2013$18m